Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.17%
#3 Velvet Velvet +37.34%
#4 Black Phoenix Black Phoenix +34.06%
#5 Akedo Akedo +29.10%
#6 Cross Cross +27.01%
#7 Cap Cap +18.79%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.46%
#9 QANplatform QANplatform +14.35%
#10 Bitway Bitway +13.02%
Coin of the day
Glidr Glidr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
HAVN Life Sciences Inc. HAVN Life Sciences Inc.

HAVN Life Sciences Inc.

HAVN
Clasificación en acciones #38701
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and... HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
Precio por acción
$0.02201811
Última sincronización: 2024-07-23
Capitalización bursátil
$847.02K
Cambio (1 día)
-0.22%
Cambio (1 año)
0.00%
País
CA
Comercio HAVN Life Sciences Inc. (HAVN)

Categoría

Healthcare
Ratio P/B de HAVN Life Sciences Inc. (HAVN)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de HAVN Life Sciences Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de HAVN Life Sciences Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE